Asian Pain Academy

Author: Dr. Debjyoti Dutta, Pain Physician Reviewed by: Dr. Chinmoy Roy, Pain Physician Introduction The year 2026 marks a pivotal moment in metabolic medicine in India . With the anticipated expiry of patent protection for semaglutide , the active molecule behind widely used anti-diabetic and anti-obesity medications, the Indian pharmaceutical landscape is poised for a major transformation. The emergence of Semaglutide Generics India 2026  is expected to significantly expan